Holderness Investments CO Bluebird Bio, Inc. Transaction History
Holderness Investments CO
- $455 Million
- Q3 2024
A detailed history of Holderness Investments CO transactions in Bluebird Bio, Inc. stock. As of the latest transaction made, Holderness Investments CO holds 15,916 shares of BLUE stock, worth $135,286. This represents 0.0% of its overall portfolio holdings.
Number of Shares
15,916
Previous 20,074
20.71%
Holding current value
$135,286
Previous $19,000
57.89%
% of portfolio
0.0%
Previous 0.0%
Shares
9 transactions
Others Institutions Holding BLUE
# of Institutions
150Shares Held
63.4MCall Options Held
264KPut Options Held
428K-
Black Rock Inc. New York, NY15.4MShares$131 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.5MShares$89 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA4.68MShares$39.8 Million0.0% of portfolio
-
Pictet Asset Management Sa Geneva 73, V84.67MShares$39.7 Million0.02% of portfolio
-
State Street Corp Boston, MA3.84MShares$32.7 Million0.0% of portfolio
About bluebird bio, Inc.
- Ticker BLUE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 77,121,800
- Market Cap $656M
- Description
- bluebird bio, Inc., a biotechnology company, researches, develops, and commercializes transformative gene therapies for severe genetic diseases. Its product candidates for severe genetic diseases include betibeglogene autotemcel for the treatment of transfusion-dependent ß-thalassemia; lovotibeglogene autotemcel for the treatment of sickle cell ...